Alyftrek 10-50-125 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DB25FZK97
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,987
Award facts
- Contract value 100% obligated
- $41,986.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alyftrek 10-50-125 mg tablets (14-count units). This firm fixed-price delivery order, valued at approximately $42,000, was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025. The contract carries no set-aside designation, and the place of performance is Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to compete effectively in Defense Logistics Agency procurement. The company maintains a robust portfolio of federal contract awards covering an extensive array of medical products, including prescription medications, biologics, vaccines, and medical consumables distributed to Department of Defense healthcare sites nationwide. This particular delivery order for Alyftrek tablets represents one of many pharmaceutical product deliveries the contractor has secured under the SPE2DB program, reinforcing its role as a key distributor for military medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FZK97?
SPE2DB25FZK97 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FZK97 worth?
The government has obligated $41,987 on SPE2DB25FZK97.
Is contract SPE2DB25FZK97 an order under another contract?
Yes. SPE2DB25FZK97 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZK97 competed?
The extent of competition for SPE2DB25FZK97 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award